Filing Details

Accession Number:
0001493152-23-034856
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-29 16:30:27
Reporting Period:
2023-09-27
Accepted Time:
2023-09-29 16:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356828 Mark Alvino 6555 Carnegie Ave., 4Th Floor
Cleveland OH 44103
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-27 6,316 $3.91 69,900 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards.
  2. Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2050 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.